Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.5299 USD
-2.91%
Market Closed
Updated:
May 13, 2024
Atara Biotherapeutics Inc
Change in Working Capital
|
Atara Biotherapeutics Inc
Change in Working Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Change in Working Capital
$15.3m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$2.8B
|
CAGR 3-Years
198%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$265.7m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-48%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Change in Working Capital?
Change in Working Capital
15.3m
USD
15.3m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Change in Working Capital amounts to 15.3m USD.
What is Atara Biotherapeutics Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
0%
0%
The average annual Change in Working Capital growth rates for Atara Biotherapeutics Inc have been -38% over the past three years .
You don't have any saved screeners yet
